Kefavet® vet. 250 mg, film-coated tablet
Kefavet® vet. 250 mg, film-coated tablet
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Kefavet® vet. 250 mg, film-coated tablet
KEFAVET vet. 250 mg plėvele dengtos tabletės
Active substance:
- Cefalexin monohydrate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate263.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Film-coated tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Orion Corporation
Marketing authorisation date:
Manufacturing sites for batch release:
- Orion Corporation
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/10/1943/001-005
Date of authorisation status change:
Reference member state:
-
Sweden
Procedure number:
- SE/V/0114/001
Concerned member states:
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Hungary
-
Iceland
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/11/2022
How useful was this page?: